Korean J Nephrol.  2003 Sep;22(5):622-628.

A Case of Mechanical Thrombolysis of Thrombosed Native Hemodialysis Fistula Using Arrow Trerotola Percutaneous Thrombolytic Device

Affiliations
  • 1Department of Internal Medicine, Yonsei University, College of Medicine, Seoul, Korea. amp97@yumc.yonsei.ac.kr
  • 2Department of Diagnostic Radiology, Yonsei University, College of Medicine, Seoul, Korea.
  • 3Institute of Kidney Disease, Yonsei University, College of Medicine, Seoul, Korea.

Abstract

Adequate care of patients with end-stage renal failure on hemodialysis requires permanent vascular access. Arteriovenous fistula obstruction due to venous thrombosis is commonly observed complication, contributing significantly to morbidity and hospitalization of dialysis patients. Percutaneous intervention using angioplasty and thrombolysis has become an accepted treatment of thrombosed vascular access and demonstrates comparable technical results and patency rates with those of surgery. Recently developed percutaneous mechanical thrombectomy (PMT) uses mechanical energy to clear thrombus percutaneously in combination with mechanical dissolution, fragmentation, and aspiration. PMT offers fast thrombus removal without complications related to thrombolytic therapy. We report a case of thrombosed hemodialysis native fistula which was successfully treated with percutaneous angioplasty and mechanical thrombolysis using newly introduced Arrow-Trerotola percutaneous thrombolytic device.

Keyword

Arteriovenous fistula obstruction; Percutaneous mechanical thrombectomy; Arrow-Trerotola percutaneous thrombolytic device

MeSH Terms

Angioplasty
Arteriovenous Fistula
Dialysis
Fistula*
Hospitalization
Humans
Kidney Failure, Chronic
Mechanical Thrombolysis*
Renal Dialysis*
Thrombectomy
Thrombolytic Therapy
Thrombosis
Venous Thrombosis
Full Text Links
  • KJN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr